ESR1 and mucinous cystadenocarcinoma: Most breast cancers with papillary structures are typically characterized as estrogen receptor (ER) positive and human epidermal growth factor receptor 2 (HER2) negative, except for tall cell carcinoma with reversed polarity and mucinous cystadenocarcinoma (45, 46).